Wild type HRAS
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (1) | Wild type HRAS, Wild type KRAS | Colorectal Adenocarcinoma | Fluorouracil, Oxaliplatin, Panitumumab | |
| FDA (1) | Wild type HRAS, Wild type KRAS | Colorectal Adenocarcinoma | Panitumumab |